Filter
412
Filtered Results: 412
Text search:
Dengue
vaccin
Featured
Recommendations
45
New Publications
121
Language
Document type
No document type
205
Studies & Reports
77
Guidelines
58
Strategic & Response Plan
28
Manuals
18
Situation Updates
10
Fact sheets
7
Training Material
5
Resource Platforms
2
Infographics
2
Countries / Regions
Global
28
Brazil
23
India
16
Congo, Democratic Republic of
13
Latin America and the Carribbean
11
Burkina Faso
10
Philippines
9
Yemen
8
Liberia
7
Kenya
6
Haiti
6
Western and Central Europe
6
Bangladesh
6
Africa
5
Sierra Leone
4
Nigeria
4
Mozambique
4
Venezuela
4
Chad
4
Indonesia
4
Myanmar / Burma
4
Nepal
3
Ghana
3
Senegal
3
Guinea
3
Western Pacific Region
3
Argentina
3
Ethiopia
3
Pakistan
3
Togo
2
Peru
2
Tanzania
2
West and Central Africa
2
Middle East and North Africa
2
Sudan
2
Central African Republic
2
Mali
2
Angola
2
North Macedonia
1
Ukraine
1
El Salvador
1
Cameroon
1
Syria
1
Iran
1
Laos
1
Niger
1
Afghanistan
1
Qatar
1
USA
1
Cambodia
1
Asia
1
Jordan
1
Germany
1
Saudi Arabia
1
South–East Asia Region
1
Paraguay
1
Mauritius
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Eastern Europe
1
Djibouti
1
Egypt
1
Palestine
1
Honduras
1
Libya
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
136
Clinical Guidelines
58
Key Resources
34
Public Health
32
Women & Child Health
20
Pharmacy & Technologies
7
Capacity Building
6
Toolboxes
Rapid Response
71
COVID-19
49
Zika
35
NTDs
30
Ebola & Marburg
20
Planetary Health
17
Natural Hazards
10
Caregiver
10
Conflict
7
Global Health Education
7
Health Financing Toolbox
5
AMR
5
Mental Health
4
Specific Hazards
4
Refugee
4
Cholera
4
Pharmacy
3
TB
2
NCDs
2
HIV
1
Polio
1
Typhoon
1
In this document, recommendations are provided on designing and implementing
a cross-sectional serosurvey using school-based sampling to estimate age-specific
DENV seroprevalence to inform a country’s national dengue vaccination program.
The document includes recommendations for methods for ...
Bula da vacina foi atualizada com nova recomendação para vacina da dengue da Sanofi Aventis para pessoas nunca infectadas pela dengue.
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 3 MAY 2024, 99th YEAR / 3 MAI 2024, 99e ANNÉE
No 18, 2024, 99, 203–224
The WHO position papers are concerned primarily with the use of vaccines in large-scale vaccination programmes.
The position papers are intended for use by...
Environmental Research Volume 151, November 2016, Pages 115-123
Dengue is the world’s most important arboviral disease in terms of number of people affected. Over the past 50 years, incidence increased 30-fold: there were approximately 390 million infections in 2010. Globalization, trade, travel,...
Dengue Vaccines: Current Status and Future Prospects
Website last accessed on 31.03.2023
Dengue vaccine for 9 to 16 year old's with previous dengue infection.
167,607 dengue cases, including 720 deaths, reported from 1 January to 27 July 2019: 97% higher than in 2018, in spite of a delayed rainy season.
Case Fatality Rate (CFR) of 0.43% as of 27 July 2019 is lower than in the same time period in 2018 (0.54%), but still significantly higher than the reg...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
Surveillance Report
During the past five decades, the incidence of dengue has increased 30-fold. Some 50–100 million new infections are estimated to occur annually in more than 100 endemic countries, with a documented further spread to previously unaffected areas; every year hundreds of thousands of severe cases ari...
Parasites & Vectors volume 15, Article number: 389 (2022)
Dengue is one of the common arboviral infections and is a public health problem in South East Asia. The aim of this systematic review and meta-analysis was to evaluate the prevalence and distribution of dengue in SAARC (South Asian Associ...
Dengue is a mosquito-borne viral disease that has rapidly spread to all regions of WHO in recent years. Dengue virus is transmitted by female mosquitoes mainly of the species Aedes aegypti and, to a lesser extent, Ae. albopictus. These mosquitoes are also vectors of chikungunya, yellow fever and Zik...
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector...
Over the past 50 years, dengue has spread from nine to over a hundred countries, making it the most rapidly spreading vector-borne disease. Yet, dengue continues to have a low profile among policy-makers and donors and does not receive the media attention it deserves. While there is no vaccine or cu...
Zika and dengue viruses remain significant public health threats. These viruses share the same Aedes (Stegomyia) mosquito vectors and geographic distributions but infections cannot be readily distinguished clinically and need to be differentiated from each other, and from other circulating arboviral...
Humanitarian emergencies, regardless of type and cause, have a number of common risk factors for communicable diseases inextricably linked to excess risk of morbidity and mortality which can come from vaccine–preventable diseases (VPDs). The reduction of VPDs is a significant aim of public-health ...
